biotech
Novel Peptide for Imaging and Drug Delivery Tool for Lymphoid Cancers
Filed in archive Diagnostics, Methodologies and Instrumentation , Drugs, Vaccines and Therapeutics by ruth on June 15, 2006
Scientists have developed a peptide that, like monoclonal antibodies, can bind to the surface of leukemia and lymphoma cells. Unlike monoclonal antibodies, however, they are
(1) smaller, and can therefore infiltrate cancer cells,
(2) more specific, and are able to differentiate normal from malignant lymphocytes, and
(3) can bind to T-cells.

Given these advantages, they may have the potential as a tool for imaging tumors, and in drug delivery.
"We believe LLP2A may be an ideal vehicle for the delivery of radionuclides, cytotoxic agents, toxins, cytokines and nanoparticles to lymphoid cancers which include non-Hodgkin's lymphoma and acute lymphocytic leukemia."

The peptide, called LLP2A, was developed by researchers from the UC Davis Cancer Center and animal trials are underway.

Permalink: Novel Peptide for Imaging and Drug Delivery Tool for Lymphoid Cancers
Tags: cancer  lymphoma  biotech  delivery  drug  drug+delivery  lymphoid+cancers  novel+peptide 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/24766
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Novel Peptide for Imaging and Drug Delivery Tool for Lymphoid Cancers:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 4 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!